Mild cognitive impairment is a stage between normal aging and dementia characterized by memory or thinking problems noticeable to the individual and family but not significantly interfering with daily activities. Most people with MCI can live independently with modest support: medication reminders, transportation assistance, reduced financial complexity, and regular safety check-ins. MCI does not always progress to dementia — some people remain stable for years.

Normal aging involves occasional forgetfulness — misplacing keys, struggling to recall a name — that does not affect functioning. Dementia involves consistent memory loss and cognitive decline that impairs daily activities: forgetting recent conversations entirely, getting lost in familiar places, repeating the same question multiple times in minutes, or being unable to manage finances, medications, or self-care. Dementia is not a normal part of aging.

A change in living situation becomes necessary when: the person is no longer safe living alone (falls, wandering, forgetting to eat or take medications); the cognitive impairment is disrupting the lives of family caregivers to an unsustainable degree; behavioral symptoms (aggression, paranoia, nighttime wandering) cannot be safely managed at home; or the physical care needs (incontinence, immobility) exceed what home caregivers can handle.

For moderate cognitive decline, options include: supervised living at home with a professional caregiver (8 to 24 hours per day); adult day programs for daytime structure and social engagement; standard assisted living with enhanced supervision if behavioral symptoms are manageable; or memory care if wandering, aggression, or significant behavioral symptoms are present. The right choice depends on the specific behavioral and physical profile.

A geriatric psychiatrist specializes in the mental health conditions of older adults, including the behavioral symptoms of dementia (agitation, depression, anxiety, psychosis). They can evaluate cognitive function, diagnose dementia type, optimize medications, manage behavioral symptoms, and provide guidance on appropriate care levels. For people with challenging behavioral symptoms, a geriatric psychiatrist evaluation before placement helps identify the right type of care setting.

A neuropsychological evaluation is a comprehensive battery of standardized cognitive tests administered by a psychologist, typically taking several hours. It measures attention, memory, language, visuospatial skills, and executive function, producing a detailed profile of cognitive strengths and deficits. It is useful for: confirming a dementia diagnosis; staging the severity; differentiating dementia types; and informing care planning about specific support needs.

Key safety risks: leaving the stove on; taking medications incorrectly (double-dosing or skipping); falling and being unable to summon help; being victimized by phone or in-person scams; driving unsafely; leaving the home and getting disoriented; failing to recognize dangerous situations (household chemicals, strangers); and being unable to respond appropriately to emergencies. A home safety evaluation is valuable for identifying and mitigating the most significant risks.

Cognitive decline that affects processing speed, spatial orientation, and reaction time creates serious driving safety risks. The conversation about stopping driving is one of the most difficult for families and often requires physician involvement. When driving stops, a comprehensive transportation plan must be established — whether through family coordination, ride services, or a move to a community where transportation is provided, as in assisted living.

Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) are used for Alzheimer’s and some other dementias to slow cognitive decline. Memantine is used in moderate to severe Alzheimer’s. No medication reverses dementia, and benefits are modest. Behavioral symptoms may be managed with antidepressants, anti-anxiety medications, or in some cases carefully chosen antipsychotics. Medication management in a facility setting is important for people with cognitive decline.

Cognitive and social engagement has been shown to slow decline and reduce behavioral symptoms in people with dementia. Activities that match the person’s residual abilities — music, art, gardening, cooking, reminiscence, games — provide meaningful engagement and reduce agitation. Memory care communities that prioritize person-centered programming over passive activities produce measurably better behavioral outcomes. Quality of programming is a key factor in memory care selection.

Severe dementia requires total care — the person cannot perform any ADLs independently, may not recognize family members, and may be non-verbal and bedbound. Care focuses on comfort, dignity, and preventing complications (pressure injuries, aspiration pneumonia, contractures). Hospice is frequently appropriate at this stage. Memory care communities and skilled nursing facilities with specialized dementia programs can provide end-stage care, often with hospice partnership.

A placement agent assesses not just diagnosis and stage but the specific behavioral profile, functional abilities, and safety risks present. They identify communities with the dementia expertise, staffing, and programming to match the individual’s current and anticipated future needs. For a family navigating cognitive decline, this expertise prevents both premature placement (before needed) and dangerous delay (waiting too long to transition to a safer environment).